All Stories

  1. Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry

    Article • International Journal of Nanomedicine, August 2015, Dove Medical Press

    Professor Marek W Radomski, Dr Krzysztof A Tomaszewski, Professor Marek W Radomski

  2. CdTe quantum dots induce activation of human platelets: implications for nanoparticle hemocompatibility

    Article • International Journal of Nanomedicine, April 2015, Taylor & Francis

    Professor Marek W Radomski, Dr Stephen Paul Samuel, Dr Namrata Jain, Professor Marek W Radomski

  3. Titanium dioxide nanoparticles enhance production of superoxide anion and alter the antioxidant system in human osteoblast cells

    Article • International Journal of Nanomedicine, February 2015, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  4. Blood biocompatibility of surface-bound multi-walled carbon nanotubes

    Article • Nanomedicine Nanotechnology Biology and Medicine, January 2015, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  5. Pegylation Increases Platelet Biocompatibility of Gold Nanoparticles

    Article • Journal of Biomedical Nanotechnology, June 2014, American Scientific Publishers

    Professor Marek W Radomski, Professor Justin D Holmes, Professor Marek W Radomski

  6. Pharmacological and toxicological effects of co-exposure of human gingival fibroblasts to silver nanoparticles and sodium fluoride

    Article • International Journal of Nanomedicine, April 2014, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  7. Nitric oxide-matrix metaloproteinase-9 interactions: Biological and pharmacological significance

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, March 2014, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  8. Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells

    Article • European Journal of Cancer, May 2013, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  9. Platelets and photodynamic cancer therapy

    Article • Photodiagnosis and Photodynamic Therapy, February 2013, Elsevier

    Professor Mathias O. Senge, Professor Marek W Radomski, Professor Marek W Radomski

  10. Nanoparticle Adhesion to the Cell Membrane and Its Effect on Nanoparticle Uptake Efficiency

    Article • Journal of the American Chemical Society, January 2013, American Chemical Society (ACS)

    Professor Marek W Radomski, Professor Marek W Radomski

  11. MMP inhibition by barbiturate homodimers

    Article • Bioorganic & Medicinal Chemistry Letters, January 2013, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  12. Targeted Delivery of Transferrin-Conjugated Liposomes to an Orthotopic Model of Lung Cancer in Nude Rats

    Article • Journal of Aerosol Medicine and Pulmonary Drug Delivery, December 2012, Mary Ann Liebert Inc

    Professor Marek W Radomski, Professor Marek W Radomski

  13. Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance

    Article • British Journal of Pharmacology, September 2012, Wiley

    Professor Marek W Radomski

  14. Mechanisms of Toxicity of Amorphous Silica Nanoparticles on Human Lung Submucosal Cells in Vitro: Protective Effects of Fisetin

    Article • Chemical Research in Toxicology, September 2012, American Chemical Society (ACS)

    Professor Marek W Radomski, Professor Marek W Radomski

  15. Approaches to the safety assessment of engineered nanomaterials (ENM) in food

    Article • Food and Chemical Toxicology, June 2012, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  16. Differential inhibition of tumour cell‐induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin

    Article • British Journal of Pharmacology, May 2012, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  17. Fisetin prevents fluoride- and dexamethasone-induced oxidative damage in osteoblast and hippocampal cells

    Article • Food and Chemical Toxicology, March 2012, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  18. Design of Barbiturate–Nitrate Hybrids that Inhibit MMP-9 Activity and Secretion

    Article • Journal of Medicinal Chemistry, February 2012, American Chemical Society (ACS)

    Professor Marek W Radomski, Professor Marek W Radomski

  19. Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis

    Article • International Journal of Nanomedicine, February 2012, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  20. The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation

    Article • International Journal of Nanomedicine, January 2012, Taylor & Francis

    Professor Marek W Radomski, Professor Justin D Holmes, Professor Marek W Radomski, Professor Hongzhou Zhang

  21. Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets

    Article • Journal of Pharmacy and Pharmacology, November 2011, Oxford University Press (OUP)

    Professor Marek W Radomski, Professor Marek W Radomski

  22. Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects

    Article • International Journal of Nanomedicine, November 2011, Taylor & Francis

    Professor Marek W Radomski

  23. N-Substituted homopiperazine barbiturates as gelatinase inhibitors

    Article • Bioorganic & Medicinal Chemistry, August 2011, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  24. Polystyrene nanoparticles activate ion transport in human airway epithelial cells

    Article • International Journal of Nanomedicine, June 2011, Taylor & Francis

    Professor Marek W Radomski

  25. NOVEL DUAL NITRIC OXIDE RELEASING ANTI-REMODELING THERAPY FOR HYPERTENSIVE HEART DISEASE

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  26. SUPERASPIRINS: NOVEL PRO-DRUGS ARE MORE EFFECTIVE THAN CONVENTIONAL ASPIRIN AND DO NOT CAUSE DIRECT GI TOXICITY

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  27. Elucidation of flow‐mediated tumour cell‐induced platelet aggregation using an ultrasound standing wave trap

    Article • British Journal of Pharmacology, March 2011, Wiley

    Professor Marek W Radomski

  28. Analysis of platelet function: role of microfluidics and nanodevices

    Article • The Analyst, January 2011, Royal Society of Chemistry

    Professor Marek W Radomski, Professor Marek W Radomski

  29. Isolation of Exosomes for Subsequent mRNA, MicroRNA, and Protein Profiling

    Article • January 2011, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  30. Extracorporeal life support

    Article • BMJ, November 2010, BMJ

    Professor Marek W Radomski

  31. The effect of new aspirin prodrugs on blood platelet and tumor cells in an ‘in vitro’ study

    Article • Toxicology Letters, July 2010, Elsevier

    Professor Marek W Radomski

  32. Isosorbide-Based Aspirin Prodrugs: Integration of Nitric Oxide Releasing Groups

    Article • Journal of Medicinal Chemistry, October 2009, American Chemical Society (ACS)

    Professor Marek W Radomski, Professor Marek W Radomski

  33. Platelet compatibility of PLGA, chitosan and PLGA–chitosan nanoparticles

    Article • Nanomedicine, October 2009, Future Medicine

    Professor Marek W Radomski, Professor Marek W Radomski

  34. NANOINTERACT: A rational approach to the interaction between nanoscale materials and living matter?

    Article • Journal of Physics Conference Series, May 2009, Institute of Physics Publishing

    Prof. Iseult Lynch, Professor Marek W Radomski, Professor Marek W Radomski

  35. A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery

    Article • Journal of Thoracic and Cardiovascular Surgery, May 2009, Elsevier

    Professor Marek W Radomski, Dr Ewa Jędrzejczyk-Patej, Professor Marek W Radomski

  36. Effect of Nanoparticulate Matter on Transepithelial Ion Fluxes in Calu-3 Cells.

    Article • April 2009, American Thoracic Society

    Professor Marek W Radomski

  37. Characterisation of the R3/1 cell line as an alveolar epithelial cell model for drug disposition studies

    Article • European Journal of Pharmaceutical Sciences, March 2009, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  38. Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK

    Article • Cell Cycle, November 2008, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  39. Matrix metalloproteinases in platelet function: coming of age

    Article • Journal of Thrombosis and Haemostasis, March 2008, Elsevier

    Professor Marek W Radomski

  40. Role of metalloproteinases in platelet function

    Article • Thrombosis Research, January 2008, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  41. Nanoparticles: pharmacological and toxicological significance

    Article • British Journal of Pharmacology, March 2007, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  42. Selectins – potential pharmacological targets?

    Article • Drug Discovery Today, November 2006, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  43. Increased Alveolar and Plasma Gelatinases Activity during Postpump Syndrome: Inhibition by Inhaled Nitric Oxide

    Article • Journal of Cardiovascular Pharmacology, September 2006, Wolters Kluwer Health

    Professor Marek W Radomski, Pr Eric Troncy, Professor Marek W Radomski

  44. Platelet Dysfunction in Asphyxiated Newborn Piglets Resuscitated with 21% and 100% Oxygen

    Article • Pediatric Research, May 2006, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  45. Alteration of Decreased Plasma NO Metabolites and Platelet NO Synthase Activity by Paroxetine in Depressed Patients

    Article • Neuropsychopharmacology, November 2005, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  46. Nanoparticle‐induced platelet aggregation and vascular thrombosis

    Article • British Journal of Pharmacology, November 2005, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  47. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: A pilot clinical study

    Article • Journal of Thoracic and Cardiovascular Surgery, April 2005, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  48. Platelet–leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases

    Article • British Journal of Pharmacology, December 2004, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  49. Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation

    Article • British Journal of Pharmacology, December 2004, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  50. Metaloproteinasas de matriz en enfermedades del tracto gastrointestinal

    Article • Gastroenterología y Hepatología, October 2004, Elsevier

    Professor Marek W Radomski

  51. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder

    Article • Biological Psychiatry, July 2004, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  52. Membrane type‐1 matrix metalloproteinase stimulates tumour cell‐induced platelet aggregation: role of receptor glycoproteins

    Article • British Journal of Pharmacology, January 2004, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  53. Metaloproteinasas de matriz en enfermedades del tracto gastrointestinal

    Article • Gastroenterología y Hepatología, January 2004, Elsevier

    Professor Marek W Radomski

  54. Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina.

    Article • International Journal of Cardiology, December 2003, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  55. Differential release of matrix metalloproteinase‐9 and nitric oxide following infusion of endotoxin to human volunteers

    Article • Acta Anaesthesiologica Scandinavica, April 2003, Wiley

    Professor Marek W Radomski

  56. Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger

    Article • Journal of Thoracic and Cardiovascular Surgery, March 2003, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  57. Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study

    Article • Thrombosis Research, January 2003, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  58. Identification, regulation and role of tissue inhibitor of metalloproteinases‐4 (TIMP‐4) in human platelets

    Article • British Journal of Pharmacology, December 2002, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  59. Mechanisms of action of proteinase‐activated receptor agonists on human platelets

    Article • British Journal of Pharmacology, March 2002, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  60. Role of von Willebrand factor in tumour cell‐induced platelet aggregation: differential regulation by NO and prostacyclin

    Article • British Journal of Pharmacology, November 2001, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  61. Pharmacological characteristics of solid‐phase von Willebrand factor in human platelets

    Article • British Journal of Pharmacology, November 2001, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  62. Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts

    Article • Journal of Thoracic and Cardiovascular Surgery, October 2001, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  63. Effects of LY117018 and the Estrogen Analogue, 17α-Ethinylestradiol, on Vascular Reactivity, Platelet Aggregation, and Lipid Metabolism in the Insulin-Resistant JCR:LA-cp Male Rat: Role of Nitric Oxide

    Article • Journal of Cardiovascular Pharmacology, January 2001, Wolters Kluwer Health

    Professor Marek W Radomski, Professor Marek W Radomski

  64. Therapeutic Effect of Phenantroline in Two Rat Models of Inflammatory Bowel Disease

    Article • Scandinavian Journal of Gastroenterology, January 2001, Taylor & Francis

    Professor Marek W Radomski

  65. Vascular Matrix Metalloproteinase-2–Dependent Cleavage of Calcitonin Gene-Related Peptide Promotes Vasoconstriction

    Article • Circulation Research, October 2000, Wolters Kluwer Health

    Professor Marek W Radomski

  66. The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates

    Article • Critical Care Medicine, July 2000, Wolters Kluwer Health

    Professor Marek W Radomski, Professor Marek W Radomski

  67. Matrix Metalloproteinase-2 Contributes to Ischemia-Reperfusion Injury in the Heart

    Article • Circulation, April 2000, Wolters Kluwer Health

    Professor Marek W Radomski

  68. Inhmition of matrix metalloproteinases(MMPs)prevents tissue injury and fibrotic complications in two rat models of inflammatory bowel disease

    Article • Gastroenterology, April 2000, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  69. Nitric Oxide and Platelet Function

    Article • January 2000, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  70. Regulation of Platelet Function

    Article • January 2000, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  71. The role of nitric oxide in the regulation of ion channels in airway epithelium: Implications for diseases of the lung

    Article • Free Radical Research, January 2000, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  72. Vascular Matrix Metalloproteinase-2 Cleaves Big Endothelin-1 Yielding a Novel Vasoconstrictor

    Article • Circulation Research, November 1999, Wolters Kluwer Health

    Professor Marek W Radomski

  73. Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells

    Article • Canadian Journal of Physiology and Pharmacology, August 1999, Canadian Science Publishing

    Professor Marek W Radomski

  74. Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by S-nitrosoglutathione

    Article • Journal of Thoracic and Cardiovascular Surgery, May 1999, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  75. Differential Inhibition of Platelet Aggregation by Indomethacin and Inhaled Nitric Oxide in Critically Ill Infants

    Article • Pediatric Research, April 1999, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  76. NO effect on hemostasis

    Article • The Journal of Pediatrics, March 1999, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  77. Nitric Oxide-Mediated Regulation of Platelet Function

    Article • January 1999, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  78. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia‐induced lung injury in newborn rats

    Article • British Journal of Pharmacology, December 1998, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  79. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin‐resistant, obese JCR:LA‐cp rats

    Article • British Journal of Pharmacology, May 1998, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  80. Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates

    Article • The Lancet, April 1998, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  81. Nitric oxide: Implications for placental biology

    Article • Placenta, January 1998, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  82. Nitric oxide and platelet function: Implications for neonatology

    Article • Seminars in Perinatology, October 1997, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  83. 1.P.104 The role of nitric oxide in the vasculopathy of the JCR:LA-cp rat

    Article • Atherosclerosis, October 1997, Elsevier

    Professor Marek W Radomski

  84. Release of gelatinase A during platelet activation mediates aggregation

    Article • Nature, April 1997, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  85. INHALED NITRIC OXIDE (NO) INHIBITS PLATELET AGGREGATION IN CRITICALLY ILL NEONATES. † 843

    Article • Pediatric Research, April 1997, Springer Science + Business Media

    Professor Marek W Radomski

  86. Regulation of Platelet Function by Nitric Oxide

    Article • January 1997, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  87. Regulation of Platelet Function by Nitric Oxide and Other Nitrogen-and Oxygen-Derived Reactive Species

    Article • January 1997, Springer Science + Business Media

    Professor Marek W Radomski

  88. Nitric oxide: Implications for placental biology

    Article • Placenta, July 1996, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  89. [9] Nitric oxide in platelets

    Article • January 1996, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  90. Nitric oxide— biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis

    Article • Atherosclerosis, December 1995, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  91. The formation of nitric oxide donors from peroxynitrite

    Article • British Journal of Pharmacology, October 1995, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  92. Direct measurement of nitric oxide in human beings

    Article • The Lancet, July 1995, Elsevier

    Professor Marek W Radomski

  93. Systemic effects of S‐nitroso‐glutathione in the human following intravenous infusion.

    Article • British Journal of Clinical Pharmacology, July 1995, Wiley

    Professor Marek W Radomski

  94. Megakaryocytes From Patients With Coronary Atherosclerosis Express the Inducible Nitric Oxide Synthase

    Article • Arteriosclerosis Thrombosis and Vascular Biology, May 1995, Wolters Kluwer Health

    Professor Marek W Radomski

  95. Nitric Oxide: Biological Mediator, Modulator and Effector

    Article • Annals of Medicine, January 1995, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  96. The Role of Nitric Oxide in Vascular Haemostasis and Thrombosis: Implications for Septicaemia and Cell Damage

    Article • January 1995, Springer Science + Business Media

    Professor Marek W Radomski

  97. Platelet Regulation and Damage in Vascular Thrombotic and Septic Disorders

    Article • January 1995, Springer Science + Business Media

    Professor Marek W Radomski

  98. Nitric oxide and the pathogenesis of heart muscle disease

    Article • European Journal of Clinical Investigation, January 1995, Wiley

    Professor Marek W Radomski

  99. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty

    Article • The Lancet, November 1994, Elsevier

    Professor Marek W Radomski

  100. Nitric oxide donors inhibit platelet spreading on surfaces coated with fibrinogen but not with fibronectin

    Article • Thrombosis Research, September 1994, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski, Prof Maria Angeles Moro

  101. Comparative pharmacology of analogues of S‐nitroso‐N‐acetyl‐dl‐penicillamine on human platelets

    Article • British Journal of Pharmacology, August 1994, Wiley

    Professor Marek W Radomski

  102. Nitric oxide in the clinical arena

    Article • Journal of Hypertension, June 1994, Wolters Kluwer Health

    Professor Marek W Radomski, Professor Marek W Radomski

  103. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide

    Article • Cardiovascular Research, July 1993, European Society of Cardiology

    Professor Marek W Radomski

  104. Direct Electrochemical Measurement of Nitric Oxide Released from Human Platelets

    Article • Biochemical and Biophysical Research Communications, July 1993, Elsevier

    Professor Marek W Radomski

  105. Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase

    Article • British Journal of Pharmacology, April 1993, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  106. The Biological and Pharmacological Role of Nitric Oxide in Platelet Function

    Article • January 1993, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  107. Nitric oxide synthase activities in human myocardium

    Article • The Lancet, January 1993, Elsevier

    Professor Marek W Radomski

  108. S‐nitroso‐glutathione inhibits platelet activation in vitro and in vivo

    Article • British Journal of Pharmacology, November 1992, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  109. Modulation of platelet aggregation by an l-arginine-nitric oxide pathway

    Article • Trends in Pharmacological Sciences, January 1991, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  110. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages

    Article • Biochemical and Biophysical Research Communications, November 1990, Elsevier

    Professor Marek W Radomski

  111. Characterization of the l‐arginine: nitric oxide pathway in human platelets

    Article • British Journal of Pharmacology, October 1990, Wiley

    Professor Marek W Radomski

  112. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

    Article • Proceedings of the National Academy of Sciences, July 1990, Proceedings of the National Academy of Sciences

    Professor Marek W Radomski

  113. Increased activity of circulating polymorphonuclear leukocytes in acute myocardial infarction

    Article • International Journal of Cardiology, June 1990, Elsevier

    Professor Marek W Radomski

  114. Endothelium-derived relaxing factor

    Article • Biochemical Pharmacology, July 1988, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  115. Isolation and washing of human platelets with nitric oxide

    Article • Thrombosis Research, May 1988, Elsevier

    Professor Marek W Radomski

  116. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium

    Article • Biochemical and Biophysical Research Communications, November 1987, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  117. The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

    Article • British Journal of Pharmacology, November 1987, Wiley

    Professor Marek W Radomski

  118. ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM

    Article • The Lancet, November 1987, Elsevier

    Professor Marek W Radomski

  119. Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets

    Article • British Journal of Pharmacology, September 1987, Wiley

    Professor Marek W Radomski

  120. Salicylates and 12-lipoxygenase activity in human washed platelets

    Article • Pharmacological Research Communications, November 1986, Elsevier

    Professor Marek W Radomski

  121. The Problems and the Promise of Prostaglandin Influences in Atherogenesis

    Article • Annals of the New York Academy of Sciences, October 1985, Wiley

    Professor Marek W Radomski

  122. An ultrastructural study of stored human platelets after washing using prostacyclin

    Article • British Journal of Haematology, June 1985, Wiley

    Professor Marek W Radomski

  123. Inhibition of human platelet aggregation by vitamin K

    Article • Thrombosis Research, January 1985, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  124. An improved method for washing of human platelets with prostacyclin

    Article • Thrombosis Research, May 1983, Elsevier

    Professor Marek W Radomski

  125. Prostacyclin prolongs viability of washed human platelets

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, September 1982, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  126. The use of prostacyclin in the separation from plasma and washing of human platelets

    Article • Prostaglandins, June 1982, Elsevier

    Professor Marek W Radomski

  127. Conversion of exogenous arachidonic acid to prostaglandins in the pulmonary circulation in vivo A human and animal study

    Article • Acta Physiologica Scandinavica, August 1981, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  128. On the mechanism of angiotensin II induced release of prostacyclin

    Article • Pharmacological Research Communications, January 1981, Elsevier

    Professor Marek W Radomski

  129. Disaggregatory action of phosphodiesterase inhibitors

    Article • Pharmacological Research Communications, January 1981, Elsevier

    Professor Marek W Radomski

  130. Angiotensin-induced release of prostacyclin (PGI2) into circulation of anaesthetized cats

    Article • Pharmacological Research Communications, September 1979, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  131. Nitric Oxide, Platelet Function, Myocardial Infarction and Reperfusion Therapies

    Article • Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  132. The Nitric Oxide-Endothelin-1 Connection

    Article • Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski